Ocular risks and precautions for use with nasal corticosteroids

被引：0
|
作者：
Stephan, S. [1 ]
Daruich, A. [2 ]
Matet, A. [3 ]
Doan, S. [1 ]
机构：
[1] Fdn Ophatlmol A Rothschild, Dept Ophthalmol, 29 Rue Manin, F-75019 Paris, France
[2] Hop Necker Enfants Malad, Dept Ophthalmol, 149 Rue Sevres, F-75015 Paris, France
[3] Inst Curie, Dept Ophthalmol, 26 Rue Ulm, F-75005 Paris, France
来源：
REVUE FRANCAISE D ALLERGOLOGIE | 2018年 / 58卷 / 05期
关键词：
Nasal corticosteroid; Central serous chorioretinopathy; Ocular risks; Steroid-induced glaucoma; Steroid-induced cataract; INTRANASAL CORTICOSTEROIDS; HYPERTENSION; GLAUCOMA;
D O I：
10.1016/j.reval.2018.04.005
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Nasal corticosteroids are indicated in various ORL conditions with very good results and reduction of systemic side effects. However, serious ophthalmological adverse effects have been reported, primarily chorioretinopathy. Glaucoma and posterior subcapsular cataract have been reported in very rare cases. The prevention of side effects induced by nasal corticosteroids consists in limiting indications and screening patients at risk. If nasal corticosteroid therapy is initiated, an annual full ophthalmic examination is recommended. The purpose of this review is to report the various ophthalmological side effects related to nasal corticosteroid use and to discuss their prevention and treatment. (C) 2018 Published by Elsevier Masson SAS.
引用
收藏
页码：386 / 388
页数：3
相关论文
共 50 条
  • [31] Risks and precautions when prescribing isotretinoin
    Reactions Weekly, 2020, 1821 (1) : 5 - 5
  • [32] BOT financial risks and its precautions
    Huang Changjiang
    Luo Lingyan
    Proceedings of 2005 International Conference on Innovation & Management, 2005, : 454 - 456
  • [33] Towards an Optimized Use of Ocular Corticosteroids: EURETINA Award Lecture 2017
    Behar-Cohen, Francine
    OPHTHALMOLOGICA, 2018, 240 (02) : 111 - 119
  • [34] Reexamination of the use of systemic corticosteroids in the treatment of ocular Behcet's disease
    Matsuura, G
    Goto, H
    Ichikawa, T
    Matsuzawa, M
    Sakai, J
    Okada, A
    Usui, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 4754 - 4754
  • [35] Treatment with nasal corticosteroids: An update
    Klimek, L.
    Schendzielorz, P.
    Hoegger, P.
    ALLERGOLOGIE, 2011, 34 (06) : 307 - 318
  • [36] Topical Corticosteroids in Nasal Polyposis
    Lydia Badia
    Valerie Lund
    Drugs, 2001, 61 : 573 - 578
  • [37] CORTICOSTEROIDS IN OTOLARYNGOLOGY - NASAL AEROSOLS
    MABRY, RL
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1989, 100 (06) : 636 - 637
  • [38] Nasal corticosteroids for children with snoring
    Alexopoulos, EI
    Kaditis, AG
    Kalampouka, E
    Kostadima, E
    Angelopoulos, NV
    Mikraki, V
    Skenteris, N
    Gourgoulianis, K
    PEDIATRIC PULMONOLOGY, 2004, 38 (02) : 161 - 167
  • [39] Topical corticosteroids in nasal polyposis
    Badia, L
    Lund, V
    DRUGS, 2001, 61 (05) : 573 - 578
  • [40] TOPICAL CORTICOSTEROIDS AND NASAL REACTIVITY
    WIHL, JA
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 : 205 - 210
12345